Hasil Pencarian - Ulrich Engelmann

  • Menampilkan 1 - 4 hasil dari 4
Perbaiki Hasil
  1. 1
    Alemtuzumab in a Large Real-Life Cohort: Interim Baseline Data of the TREAT-MS Study

    Alemtuzumab in a Large Real-Life Cohort: Interim Baseline Data of the TREAT-MS Study oleh Tjalf Ziemssen, Frank Hoffmann, Stephan Richter, Ulrich Engelmann, Robin White

    Diterbitkan 2021-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Real-life outcomes of teriflunomide treatment in patients with relapsing multiple sclerosis: TAURUS-MS observational study

    Real-life outcomes of teriflunomide treatment in patients with relapsing multiple sclerosis: TAURUS-MS observational study oleh Boris A. Kallmann, Klaus Tiel-Wilck, Jennifer S. Kullmann, Ulrich Engelmann, Andrew Chan

    Diterbitkan 2019-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Teriflunomide in relapsing-remitting multiple sclerosis: outcomes by age and pre-treatment status

    Teriflunomide in relapsing-remitting multiple sclerosis: outcomes by age and pre-treatment status oleh Boris A. Kallmann, Stefan Ries, Jennifer S. Kullmann, Laura M. Quint, Ulrich Engelmann, Andrew Chan

    Diterbitkan 2021-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Size-isolation of superparamagnetic iron oxide nanoparticles improves MRI, MPI and hyperthermia performance

    Size-isolation of superparamagnetic iron oxide nanoparticles improves MRI, MPI and hyperthermia performance oleh Seyed Mohammadali Dadfar, Denise Camozzi, Milita Darguzyte, Karolin Roemhild, Paola Varvarà, Josbert Metselaar, Srinivas Banala, Marcel Straub, Nihan Güvener, Ulrich Engelmann, Ioana Slabu, Miriam Buhl, Jan van Leusen, Paul Kögerler, Benita Hermanns-Sachweh, Volkmar Schulz, Fabian Kiessling, Twan Lammers

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: